Bruce Keyt Igm Biosciences, Inc. (IGMS) insider trading activity

Bruce Keyt is CHIEF SCIENTIFIC OFFICER of IGM Biosciences, Inc.. Currently has a direct ownership of 242,948 shares of IGMS, which is worth approximately $3.17 Million. The most recent transaction as insider was on Sep 06, 2022, when has been sold 5,000 shares (Common Stock) at a price of $19.06 per share, resulting in proceeds of $95,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243K

0.61% 3M change

75.98% 12M change

Total Value Held $3.17 Million

Bruce Keyt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 06 2022	SELL Open market or private sale	$95,300 $19.06 p/Share	5,000 Reduced 11.24%	39,489 Common Stock
Sep 06 2022	BUY Exercise of conversion of derivative security	$4,650 $0.93 p/Share	5,000 Added 10.1%	44,489 Common Stock
Aug 22 2022	SELL Open market or private sale	$130,473 $20.71 p/Share	6,300 Reduced 13.76%	39,489 Common Stock
Aug 22 2022	BUY Exercise of conversion of derivative security	$5,859 $0.93 p/Share	6,300 Added 12.09%	45,789 Common Stock
Aug 19 2022	SELL Open market or private sale	$198,534 $22.82 p/Share	8,700 Reduced 18.05%	39,489 Common Stock
Aug 19 2022	BUY Exercise of conversion of derivative security	$8,091 $0.93 p/Share	8,700 Added 15.29%	48,189 Common Stock
Aug 18 2022	SELL Open market or private sale	$225,400 $22.54 p/Share	10,000 Reduced 20.21%	39,489 Common Stock
Aug 18 2022	BUY Exercise of conversion of derivative security	$9,300 $0.93 p/Share	10,000 Added 16.81%	49,489 Common Stock
May 24 2022	SELL Open market or private sale	$16,057 $17.1 p/Share	939 Reduced 2.32%	39,489 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	$5,113 $12.38 p/Share	413 Added 1.01%	40,428 Common Stock
Apr 06 2022	SELL Open market or private sale	$62,500 $25.0 p/Share	2,500 Reduced 5.88%	40,015 Common Stock
Apr 06 2022	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 5.55%	42,515 Common Stock
Mar 30 2022	SELL Open market or private sale	$213,750 $28.5 p/Share	7,500 Reduced 15.78%	40,015 Common Stock
Mar 30 2022	BUY Exercise of conversion of derivative security	$6,975 $0.93 p/Share	7,500 Added 13.63%	47,515 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	14,319 Added 26.35%	40,015 Common Stock
Mar 12 2022	BUY Grant, award, or other acquisition	-	12,500 Added 32.73%	25,696 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	10,000 Added 43.11%	13,196 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	$7,088 $50.99 p/Share	139 Added 4.17%	3,196 Common Stock
Nov 02 2021	SELL Open market or private sale	$68,117 $51.37 p/Share	1,326 Reduced 30.25%	3,057 Common Stock
Nov 01 2021	SELL Payment of exercise price or tax liability	$58,442 $49.78 p/Share	1,174 Reduced 21.13%	4,383 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 31.03%	5,557 Common Stock
Oct 05 2021	SELL Open market or private sale	$79,612 $64.1 p/Share	1,242 Reduced 28.89%	3,057 Common Stock
Oct 01 2021	SELL Payment of exercise price or tax liability	$82,915 $65.91 p/Share	1,258 Reduced 22.64%	4,299 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$2,325 $0.93 p/Share	2,500 Added 31.03%	5,557 Common Stock
Sep 03 2021	SELL Open market or private sale	$87,938 $70.69 p/Share	1,244 Reduced 28.92%	3,057 Common Stock

Bruce Keyt

CHIEF SCIENTIFIC OFFICER

Mountain View, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Value

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IGM Biosciences, Inc.

Track Activities on IGMS

Account